Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer

Colorectal Disease

Volumn 15, Issue 9, 2013, Pages 1107-1114

  Barsukov, Yu A ^a   Gordeyev, S S ^a,b   Tkachev, S I ^a   Fedyanin, M Yu ^a   Perevoshikov, A G ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Chemoradiotherapy; Fixed rectal cancer; Hyperthermia; Metronidazole

Indexed keywords

CAPECITABINE; DEXAMETHASONE; METRONIDAZOLE; ONDANSETRON; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; ASTHENIA; BLADDER FISTULA; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; COLON ANASTOMOSIS; CYSTITIS; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; HYPOTONIC BLADDER; INOPERABLE CANCER; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; NEUROPATHY; OVERALL SURVIVAL; PELVIC INFLAMMATORY DISEASE; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION; RECTUM CANCER; RECTUM RESECTION; RECURRENCE RISK; SKIN MANIFESTATION; SURVIVAL TIME; TENESMUS; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; VEIN THROMBOSIS; VOMITING;

CHEMORADIOTHERAPY; FIXED RECTAL CANCER; HYPERTHERMIA; METRONIDAZOLE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; HYPERTHERMIA, INDUCED; MALE; METRONIDAZOLE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RADIATION-SENSITIZING AGENTS; RECTAL NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884719188     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12281     Document Type: Article

References (56)

1. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60.
2. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-46.
3. Zaheer S, Pemberton JH, Farouk R, Dozois RR, Wolff BG, Ilstrup D. Surgical treatment of adenocarcinoma of the rectum. Ann Surg 1998; 227: 800-11.
4. Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ. Abdominoperineal excision of the rectum - an endangered operation. Norman Nigro Lectureship. Dis Colon Rectum 1997; 40: 747-51.
5. Sauer R, Liersch T, Merkel S et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012; 30: 1926-33.
6. Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007; (2): CD002102.
7. Horisberger K, Treschl A, Mai S et al. Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a phase II MARGIT trial. Intl J Radiat Oncol Biol Phys 2009; 74: 1487-93.
8. Capirci C, Rubello D, Pasini F et al. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Intl J Radiat Oncol Biol Phys 2009; 74: 1461-9.
9. Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Stahl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003; 42: 476-92.
10. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001; 19: 1976-84.
11. Braendengen M, Tveit KM, Berglund A et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26: 3687-94.
12. Bulow S, Jensen LH, Altaf R et al. A national cohort study of long-course preoperative radiotherapy in primary fixed rectal cancer in Denmark. Colorectal Dis 2010; 12: e18-23.
13. Ferrigno R, Novaes PE, Silva ML et al. Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors. Radiat Oncol 2006; 1: 5.
14. Mathis KL, Nelson H, Pemberton JH, Haddock MG, Gunderson LL. Unresectable colorectal cancer can be cured with multimodality therapy. Ann Surg 2008; 248: 592-8.
15. Overgaard J, Hansen HS, Overgaard M et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 1998; 46: 135-46.
16. Deutsch G, Foster JL, McFadzean JA, Parnell M. Human studies with 'high dose' metronidazole: a non-toxic radiosensitizer of hypoxic cells. Br J Cancer 1975; 31: 75-80.
17. Overgaard J. Hypoxic radiosensitization: adored and ignored. J Clin Oncol 2007; 25: 4066-74.
18. Galecki J, Dukowicz A, Hliniak A et al. [Comparison of the effectiveness of different methods of irradiation using metronidazole as a radiation-sensitizing agent in patients with laryngeal cancer. Controlled clinical studies]. Nowotwory 1989; 39: 111-5.
19. Goldobenko GV, Kherkheulidze Z, Shchebetenko IE, Polotskii BE. Analysis of clinical experience in the use of metronidazole as a radiosensitizer of tumors. Meditsinskaia Radiologiia 1983; 28: 70-6.
20. Leunig M, Goetz AE, Dellian M et al. Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response. Cancer Res 1992; 52: 487-90.
21. Lefor AT, Makohon S, Ackerman NB. The effects of hyperthermia on vascular permeability in experimental liver metastasis. J Surg Oncol 1985; 28: 297-300.
22. Barsukov IA, Tkachev SI, Oltarzhevskaia ND et al. Combined treatment for rectal cancer using different radiomodification means. Vopr Onkol 2008; 54: 350-3.
23. Barsukov IA, Tkachev SI, Oltarzhevskaia ND et al. Polyradiomodification as component of combined treatment of rectal cancer: rationale and results. Vopr Onkol 2010; 56: 66-9.
24. Knysh VI, Goldobenko GV, Ozhiganov EL, Barsukov IA. [Combined treatment of cancer of the rectum]. Sovetskaia Meditsina 1987; 2: 14-8.
25. De Haas-Kock DF, Buijsen J, Pijls-Johannesma M et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev 2009; (3): CD006269.
26. Arcangeli G, Nervi C, Cividalli A, Lovisolo GA. Problem of sequence and fractionation in the clinical application of combined heat and radiation. Cancer Res 1984; 44: 4857s-63s.
27. Hazan G, Ben-Hur E. Radiotherapy combined with hyperthermia: the fractionation problem. J Radiat Res 1979; 20: 243-7.
28. Mardynskii IS, Titova LN, Sidorchenkov VO, Menteshashvili GZ, Zagrebin VM. Thermoradiotherapy of rectal cancer. Meditsinskaia Radiologiia 1988; 33: 13-7.
29. Koukourakis MI, Simopoulos C, Pitiakoudis M et al. Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in the treatment of rectal cancer: a feasibility study. Anticancer Res 2008; 28: 3035-40.
30. Gollins SW, Myint S, Susnerwala S et al. Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2). Br J Cancer 2009; 101: 924-34.
31. Rodel C, Grabenbauer GG, Schick C, Papadopoulos T, Hohenberger W, Sauer R. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Strahlentherapie Onkologie 2000; 176: 161-7.
32. Chau I, Brown G, Cunningham D et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-74.
33. Gerard JP, Azria D, Gourgou-Bourgade S et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010; 28: 1638-44.
34. Takemoto M, Kuroda M, Urano M et al. The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours. Intl J Hypertherm 2003; 19: 193-203.
35. Overgaard J. Effect of hyperthermia on the hypoxic fraction in an experimental mammary carcinoma in vivo. Br J Radiol 1981; 54: 245-9.
36. Laszlo A, Fleischer I. Heat-induced perturbations of DNA damage signaling pathways are modulated by molecular chaperones. Cancer Res 2009; 69: 2042-9.
37. Song CW, Shakil A, Osborn JL, Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures, 1996. Intl J Hypertherm 2009; 25: 91-5.
38. Song CW, Park H, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001; 155: 515-28.
39. Herman TS, Teicher BA, Jochelson M, Clark J, Svensson G, Coleman CN. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Intl J Hypertherm 1988; 4: 143-58.
40. Miller RC, Richards M, Baird C, Martin S, Hall EJ. Interaction of hyperthermia and chemotherapy agents; cell lethality and oncogenic potential. Intl J Hypertherm 1994; 10: 89-99.
41. Hahn GM, Shiu EC. Effect of pH and elevated temperatures on the cytotoxicity of some chemotherapeutic agents on Chinese hamster cells in vitro. Cancer Res 1983; 43: 5789-91.
42. Schroeder C, Gani C, Lamprecht U et al. Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone. Intl J Hypertherm 2012; 28: 707-14.
43. Bonvalot S, de Baere T, Mendiboure J et al. Hyperthermic pelvic perfusion with tumor necrosis factor-alpha for locally advanced cancers: encouraging results of a phase II study. Ann Surg 2012; 255: 281-6.
44. Barsukov IA, Vlasov OA, Tkachev SI et al. Use of combined treatment of rectal cancer involving metastases to regional lymph nodes. Vopr Onkol 2006; 52: 521-4.
45. Frykholm GJ, Pahlman L, Glimelius B. Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Intl J Radiat Oncol Biol Phys 2001; 50: 427-34.
46. Vestermark LW, Jacobsen A, Qvortrup C et al. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Acta Oncol 2008; 47: 428-33.
47. Videtic GM, Fisher BJ, Perera FE et al. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Intl J Radiat Oncol Biol Phys 1998; 42: 319-24.
48. Bujko K. Timing of surgery following preoperative therapy in rectal cancer: there is no need for a prospective randomized trial. Dis Colon Rectum 2012; 55: e31. author reply e32.
49. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Intl J Colorectal Dis 1997; 12: 19-23.
50. Suarez J, Vera R, Balen E et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis 2008; 10: 563-8.
51. Losi L, Luppi G, Gavioli M et al. Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy. Intl J Colorectal Dis 2006; 21: 645-51.
52. Ryan DP, Niedzwiecki D, Hollis D et al. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 2006; 24: 2557-62.
53. Gerard JP, Chapet O, Nemoz C et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 2003; 21: 1119-24.
54. Rau B, Wust P, Tilly W et al. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. Intl J Radiat Oncol Biol Phys 2000; 48: 381-91.
55. Carlomagno C, Farella A, Bucci L et al. Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study. Ann Oncol 2009; 20: 906-12.
56. Kim JS, Cho MJ, Song KS, Yoon WH. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Intl J Radiat Oncol Biol Phys 2002; 54: 403-8.